Dauch Corp: Form 10-K for the period ended Dec 31, 2014
Filed with the SEC on Feb 23, 2015 and accepted by EDGAR at Feb 23, 2015, 09:47 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-10-01 to 2014-12-31 | $939.5m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 12 months2014-01-01 to 2014-12-31 | $3.70bn | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 12 months2014-01-01 to 2014-12-31 | $3.17bn | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2014-10-01 to 2014-12-31 | $111.2m | us-gaap:GrossProfit |
| Gross profit | 12 months2014-01-01 to 2014-12-31 | $522.8m | us-gaap:GrossProfit |
| Research and development | 12 months2014-01-01 to 2014-12-31 | $103.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2014-01-01 to 2014-12-31 | $255.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2014-01-01 to 2014-12-31 | $267.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2014-01-01 to 2014-12-31 | $99.9m | us-gaap:InterestExpense |
| Income tax | 12 months2014-01-01 to 2014-12-31 | $33.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-10-01 to 2014-12-31 | $13.2m | us-gaap:NetIncomeLoss |
| Net income | 12 months2014-01-01 to 2014-12-31 | $143.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-10-01 to 2014-12-31 | $0.17 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2014-01-01 to 2014-12-31 | $1.85 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-10-01 to 2014-12-31 | $0.17 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2014-01-01 to 2014-12-31 | $1.85 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2014-01-01 to 2014-12-31 | 75,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2014-01-01 to 2014-12-31 | $318.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2014-01-01 to 2014-12-31 | $206.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2014-01-01 to 2014-12-31 | $300.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-12-31 | $249.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-12-31 | $1.14bn | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-31 | $3.26bn | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $687.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-12-31 | $3.15bn | us-gaap:Liabilities |
| Current portion of debt | At period end2014-12-31 | $13.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2014-12-31 | $113.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001062231-15-000023. Last ingested by Listed: Nov 6, 2026, 13:29 ET. Listed shows no prices and gives no investment advice.